|
|
|
Insider
Information: |
Kim Mina |
Relationship: |
Chief Executive Office... |
City: |
San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
803,161 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$5,610,601 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
803,161 |
|
|
Total
Value |
$5,610,601 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
5
|
Stock
price went up :
|
0
|
4
|
Stock
price went down : |
1
|
1
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
4.0
|
Percentage
Gain/Loss : |
-71.0%
|
161.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Sunrun Inc. |
RUN |
General Counsel |
2017-03-15 |
327,606 |
|
0 |
Premium* |
|
Atara Biotherapeutics, Inc. |
ATRA |
Senior VP & General Co... |
2019-04-09 |
66,389 |
2018-04-09 |
0 |
Premium* |
|
Zymergen Inc. |
ZY |
Chief Legal Officer |
2022-09-02 |
298,427 |
2021-10-26 |
0 |
Premium* |
|
Acelyrin, Inc. |
SLRN |
Chief Executive Office... |
2024-05-15 |
110,739 |
2023-05-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
RUN |
Sunrun Inc. |
General CounselOfficer |
|
2016-03-03 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
109,506 |
|
- |
|
RUN |
Sunrun Inc. |
General Counsel |
|
2016-11-08 |
4 |
A |
$0.00 |
$0 |
D/D |
87,100 |
196,606 |
0 |
- |
|
RUN |
Sunrun Inc. |
General Counsel |
|
2017-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
131,000 |
327,606 |
0 |
- |
|
ATRA |
Atara Biotherapeutics, In... |
Senior VP & General Counsel |
|
2018-04-09 |
4 |
A |
$0.00 |
$0 |
D/D |
42,500 |
42,500 |
0 |
- |
|
ATRA |
Atara Biotherapeutics, In... |
Senior VP & General Counsel |
|
2019-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
17,063 |
60,063 |
0 |
- |
|
ATRA |
Atara Biotherapeutics, In... |
Senior VP & General Counsel |
|
2019-03-26 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
70,063 |
0 |
- |
|
ATRA |
Atara Biotherapeutics, In... |
Senior VP & General Counsel |
|
2019-04-09 |
4 |
D |
$36.85 |
$135,387 |
D/D |
(3,674) |
66,389 |
0 |
- |
|
ZY |
Zymergen Inc. |
Chief Legal Officer |
|
2021-10-26 |
4 |
A |
$0.00 |
$0 |
D/D |
97,000 |
97,000 |
0 |
- |
|
ZY |
Zymergen Inc. |
Chief Legal Officer |
|
2022-03-11 |
4 |
A |
$0.00 |
$0 |
D/D |
217,000 |
314,000 |
0 |
- |
|
ZY |
Zymergen Inc. |
Chief Legal Officer |
|
2022-05-02 |
4 |
S |
$1.79 |
$5,740 |
D/D |
(3,206) |
310,794 |
0 |
% |
|
ZY |
Zymergen Inc. |
Chief Legal Officer |
|
2022-06-02 |
4 |
S |
$1.68 |
$4,930 |
D/D |
(2,939) |
307,855 |
0 |
% |
|
ZY |
Zymergen Inc. |
Chief Legal Officer |
|
2022-07-05 |
4 |
S |
$1.32 |
$3,866 |
D/D |
(2,924) |
304,931 |
0 |
% |
|
ZY |
Zymergen Inc. |
Chief Legal Officer |
|
2022-08-02 |
4 |
S |
$2.61 |
$8,083 |
D/D |
(3,094) |
301,837 |
0 |
% |
|
ZY |
Zymergen Inc. |
Chief Legal Officer |
|
2022-09-02 |
4 |
S |
$2.21 |
$7,536 |
D/D |
(3,410) |
298,427 |
0 |
% |
|
SLRN |
Acelyrin, Inc. |
Chief Legal & Admin. Officer |
|
2023-05-09 |
4 |
B |
$18.00 |
$90,000 |
D/D |
5,000 |
5,000 |
2.74 |
% |
|
SLRN |
Acelyrin, Inc. |
Chief Legal & Admin. Officer |
|
2023-08-16 |
4 |
A |
$0.00 |
$0 |
D/D |
114,676 |
119,676 |
0 |
- |
|
SLRN |
Acelyrin, Inc. |
Chief Executive Officer |
|
2024-05-15 |
4 |
D |
$4.47 |
$45,728 |
D/D |
(10,230) |
110,739 |
0 |
- |
|
17 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|